secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYNAVAX TECHNOLOGIES CORP (—)
CIK:        0001029142
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001029142-25-000081
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Dynavax appoints Joseph Metzinger as VP and Chief Accounting Officer
--------------------------------------------------------------------

- Appointment effective May 12, 2025; Metzinger becomes principal accounting officer.
- Annual base salary of $315,000 with bonus eligibility up to 40% of base salary.
- Granted 38,182 RSUs and 31,500 stock options, each vesting over three years.
- Metzinger had served as a consultant to Dynavax since 2024; prior roles include CAO at a public biotech.
- Kelly MacDonald remains Senior VP, CFO and principal financial officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1029142/000102914225000081/0001029142-25-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1029142/000102914225000081/dvax-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001029142-25-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer